Investors
MEDICAL MARIJUANA, INC. (MJNA)
| LAST | 0.0365 | Change | -0.001 |
| OPEN | 0.0385 | Change % | 2.67% |
| HIGH | 0.0385 | 52 Week Range | 0.0347 - 0.11 |
| LOW | 0.0347 | Days Range | 0.0347 - 0.0385 |
| VOLUME | 9935670 | Market Cap (real-time) | N/A |
Last Updated: 09-20-2019 (US/Eastern)
About Us
Get to know our team and portfolio
Our History
We Are a Company of Firsts®
Press Releases
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Super Academy Event and Product Launch in Amsterdam
SAN DIEGO, Sept. 19, 2019 -- Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company…
September 19, 2019
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Signs Agreement with Online Marketplace Dr. Cannabis
SAN DIEGO, Sept. 17, 2019 -- Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company…
September 17, 2019
Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies Begins GMP Manufacturing Of Cannabinoid-Based Gum With Dronabinol For Use In Upcoming Clinical Studies
SAN DIEGO, Sept. 12, 2019 -- Medical Marijuana, Inc. (OTC:MJNA) ("the Company"), the first-ever publicly traded cannabis company…
September 12, 2019
Media coverage
Medical Marijuana, Inc. Featured on Benzinga, Yahoo Finance, and More
The development of new cannabinoid products, expanded Medical Marijuana, Inc. operations, CBD reviews, and advocating…
August 24, 2019
Medical Marijuana, Inc. Announces Second Quarter Filing Date and Schedules Investor Conference Call for August 15, 2019
SAN DIEGO, Aug. 12, 2019 -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in…
August 13, 2019
Forbes, Fox Business, U.S. News & World Report Among Media Outlets Featuring Medical Marijuana, Inc.
CBD and potential FDA regulation, CBD in Europe, and CBD disrupting the direct selling market…
June 17, 2019